Article info
PDFCurrent controversy
Three for me and none for you? An ethical argument for delaying COVID-19 boosters
- Correspondence to Dr Nancy S Jecker, University of Washington School of Medicine, Department of Bioethics & Humanities, Seattle, WA 98195-7120, USA; nsjecker{at}uw.edu
Citation
Three for me and none for you? An ethical argument for delaying COVID-19 boosters
Publication history
- Received August 18, 2021
- Accepted October 3, 2021
- First published October 7, 2021.
Online issue publication
September 28, 2022
Article Versions
- Previous version (7 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- It is not too late to achieve global covid-19 vaccine equity
- Vaccine passports and health disparities: a perilous journey
- Vaccine equity in COVID-19: a meta-narrative review
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Towards a new model of global health justice: the case of COVID-19 vaccines
- Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis
- Considerations for vaccinating children against COVID-19
- Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
- Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis